Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
4.810
-0.240 (-4.75%)
At close: Nov 12, 2026, 4:00 PM EST
4.600
-0.210 (-4.37%)
After-hours: Nov 12, 2026, 5:08 PM EST
Shattuck Labs Market Cap
Shattuck Labs has a market cap or net worth of $489.86 million as of November 12, 2026. It is the 14,277th most valuable company in the world and the 2,698th biggest in the United States. Its market cap has increased by 290.97% in one year.
Market Cap
489.86M
Enterprise Value
296.00M
1-Year Change
290.97%
Global Rank
Country Rank
#2,698 United States
Category
ChartMarket Cap Chart
Since the IPO on October 9, 2020, Shattuck Labs's market cap has decreased from $677.31M to $489.86M, a decrease of -27.68%. That is a compound annual growth rate of -5.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 489.86M | 112.09% |
| Dec 31, 2025 | 230.97M | 299.85% |
| Dec 31, 2024 | 57.77M | -82.81% |
| Dec 29, 2023 | 336.08M | 244.71% |
| Dec 30, 2022 | 97.50M | -72.88% |
| Dec 31, 2021 | 359.52M | -83.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 531.20M |
| Ovid Therapeutics | 524.67M |
| DiaMedica Therapeutics | 520.92M |
| Neurogene | 519.59M |
| BlossomHill Therapeutics | 512.37M |
| Phathom Pharmaceuticals | 498.82M |
| Indaptus Therapeutics | 493.00M |
| Avalo Therapeutics | 492.07M |